The label states that patients with diabetes taking Wegovy in combination with those agents may have an increased risk of hypoglycemia, including severe hypoglycemia
Source: The New England Journal of Medicine Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff et al., 2022) Figure 1A Average Weight Loss After 72 Weeks At 72 weeks, participants taking tirzepatide once weekly lost significantly more weight than those on placebo: 5 mg dose: 15.0% average body weight reduction 10 mg dose: 19.5% reduction 15 mg dose: 20.9% reduction Placebo: 3.1% reduction All tirzepatide doses showed much greater weight loss compared to placebo
Related Content Subscribe Go ahead, you deserve to feel fantastic By subscribing you agree to our Terms of Service & Privacy Policy.
This gives your digestive system, particularly your gut microbiome, time to adapt
Schedule your consultation today and get clear answers, a personalized plan, and real support from a team that cares.
It may have a red or pinkish tint if its mixed with B12